Cargando…

Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial

IMPORTANCE: Selenium and vitamin E have been identified as promising agents for the chemoprevention of recurrence and progression of non–muscle-invasive bladder cancer. OBJECTIVE: To determine whether selenium and/or vitamin E may prevent disease recurrence in patients with newly diagnosed NMIBC. DE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bryan, Richard T., Pirrie, Sarah J., Abbotts, Ben, Maycock, Shanna, During, Vinnie, Lewis, Carolyn, Grant, Margaret, Bird, Deborah, Devall, Adam J., Wallace, D. Michael A., James, Nicholas D., Billingham, Lucinda J., Zeegers, Maurice P., Cheng, K. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582794/ https://www.ncbi.nlm.nih.gov/pubmed/37847504 http://dx.doi.org/10.1001/jamanetworkopen.2023.37494

Ejemplares similares

Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
por: Dowell, Alexander C., et al.
Publicado: (2017)

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015)

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)

Patients choose certainty over burden in bladder cancer surveillance
por: van Osch, Frits H. M., et al.
Publicado: (2019)

Health‐related quality of life around the time of diagnosis in patients with bladder cancer
por: Yu, Evan Yi‐Wen, et al.
Publicado: (2019)

Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumours
por: Llewellyn, Matthew A., et al.
Publicado: (2018)

STAG2 Protein Expression in Non–muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes
por: Gordon, Naheema S., et al.
Publicado: (2022)

Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)
por: Goossens, Maria (Mieke), et al.
Publicado: (2015)

The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study
por: van Osch, Frits H. M., et al.
Publicado: (2018)

Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification
por: Ward, Douglas G., et al.
Publicado: (2019)

Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study
por: Jochems, Sylvia H.J., et al.
Publicado: (2018)

Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer
por: Kitchen, Mark O., et al.
Publicado: (2015)

Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study
por: Jochems, Sylvia H. J., et al.
Publicado: (2018)

Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
por: Goossens, Maria E, et al.
Publicado: (2012)

Back-Splicing Transcript Isoforms (Circular RNAs) Affect Biologically Relevant Pathways and Offer an Additional Layer of Information to Stratify NMIBC Patients
por: Goel, Anshita, et al.
Publicado: (2020)

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA
por: Togneri, Fiona S, et al.
Publicado: (2016)

Selenium and risk of bladder cancer
por: Złowocka-Perłowska, E, et al.
Publicado: (2012)

Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes
por: Goel, Anshita, et al.
Publicado: (2022)

Do the methods used to analyse missing data really matter? An examination of data from an observational study of Intermediate Care patients
por: Kaambwa, Billingsley, et al.
Publicado: (2012)

Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer
por: Lipunova, Nadezda, et al.
Publicado: (2019)

External Replication of Urinary Bladder Cancer Prognostic Polymorphisms in the UK Biobank
por: Lipunova, Nadezda, et al.
Publicado: (2019)

Toenail selenium concentrations and bladder cancer risk in women and men
por: Michaud, D S, et al.
Publicado: (2005)

Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study
por: Brinkman, Maree T., et al.
Publicado: (2009)

Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification
por: Snell, Kym I.E., et al.
Publicado: (2018)

Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size
por: Lipunova, Nadezda, et al.
Publicado: (2020)

The effectiveness of varicocele embolisation for the treatment of varicocele related orchalgia
por: Muthuveloe, David W, et al.
Publicado: (2015)

Erratum to: The effectiveness of varicocele embolisation for the treatment of varicocele related orchalgia
por: Muthuveloe, David W, et al.
Publicado: (2015)

Erratum to: Total Fluid Intake and the Risk of Recurrence in Patients with Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study
por: Jochems, Sylvia H.J., et al.
Publicado: (2020)

Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial
por: Dillon, Richard, et al.
Publicado: (2022)

Crossing survival curves: alternatives to the log-rank test
por: Bouliotis, George, et al.
Publicado: (2011)

Choice of transformation for modelling non-linear continuous biomarkers
por: Stocken, Deborah D, et al.
Publicado: (2011)

A Stratified Meta-Analysis of the Association between Exposure to Environmental Tobacco Smoke during Childhood and Adulthood and Urothelial Bladder Cancer Risk
por: van Osch, Frits H. M., et al.
Publicado: (2018)

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations
por: Hubner, Richard A., et al.
Publicado: (2011)

Meta-analysis of randomized phase II trials to inform subsequent phase III decisions
por: Burke, Danielle L, et al.
Publicado: (2014)

Dietary intake of micronutrients and the risk of developing bladder cancer: results from the Belgian case–control study on bladder cancer risk
por: Brinkman, Maree T., et al.
Publicado: (2011)

HumanMethylation450K Array–Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer
por: Kitchen, Mark O, et al.
Publicado: (2018)

Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection
por: Baxter, L., et al.
Publicado: (2023)

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
por: Yap, Christina, et al.
Publicado: (2011)

Evaluation of methods to adjust for treatment switching in clinical trials
por: Fox, Richard, et al.
Publicado: (2011)

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
por: Yap, Christina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t0k3ac0so4e07al0m088bduppb